| Schedule of Segment Information |
The
following table is a summary of segment information for three months ended March 31, 2026 and 2025 (amounts in thousands):
Schedule
of Segment Information
| |
|
March
31, 2026 |
|
|
March
31, 2025 |
|
| |
|
For
the three months ended |
|
| |
|
March
31, 2026 |
|
|
March
31, 2025 |
|
| Net revenues |
|
|
|
|
|
|
|
|
| Diagnostic services |
|
$ |
- |
|
|
$ |
- |
|
| Consumer
products |
|
|
478 |
|
|
|
1,431 |
|
| Consolidated net revenue |
|
|
478 |
|
|
|
1,431 |
|
| Cost of revenue |
|
|
|
|
|
|
|
|
| Diagnostic services |
|
|
- |
|
|
|
232 |
|
| Consumer
products |
|
|
311 |
|
|
|
673 |
|
| Consolidated cost of revenue |
|
|
311 |
|
|
|
905 |
|
| Depreciation and amortization
expense |
|
|
|
|
|
|
|
|
| Diagnostic services |
|
|
- |
|
|
|
334 |
|
| Consumer
products |
|
|
623 |
|
|
|
807 |
|
| Total Depreciation and
amortization expense |
|
|
623 |
|
|
|
1,141 |
|
| Operating and other expenses |
|
|
|
|
|
|
|
|
| Diagnostic services |
|
|
- |
|
|
|
168 |
|
| Consumer products |
|
|
562 |
|
|
|
1,061 |
|
| Unallocated
corporate |
|
|
2,962 |
|
|
|
2,834 |
|
| Total operating and other
expenses |
|
|
3,524 |
|
|
|
4,063 |
|
| Income (loss) from operations,
before income taxes |
|
|
|
|
|
|
|
|
| Income
tax expense |
|
|
(1,374 |
)
|
|
|
- |
|
| Total
loss from operations, after income taxes |
|
|
(5,354 |
) |
|
|
(4,678 |
) |
| Net
loss from continuing operations |
|
$ |
(5,354 |
) |
|
$ |
(4,678 |
) |
The
following table is a summary of segment information as of March 31, 2026 and December 31, 2025 (amounts in thousands):
| |
|
March
31, 2026 |
|
|
December
31, 2025 |
|
| ASSETS |
|
|
|
|
|
|
|
|
| Consumer products |
|
$ |
10,973 |
|
|
$ |
11,614 |
|
| Unallocated corporate |
|
|
47,757 |
|
|
|
48,257 |
|
| Total assets |
|
$ |
58,730 |
|
|
$ |
59,871 |
|
|